Stock KROS KEROS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Keros Therapeutics, Inc.

Equities

KROS

US4923271013

Market Closed - Nasdaq
Other stock markets
 01:30:00 15/05/2024 am IST 		5-day change 1st Jan Change
52.8 USD -2.22% Intraday chart for Keros Therapeutics, Inc. -10.02% +32.80%
08/05 Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 MT
08/05 Keros Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
KEROS THERAPEUTICS, INC. Stock Keros Therapeutics, Inc.
 1.95B -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
BIONTECH SE Stock BioNTech SE
 22.34B -
ARGENX SE Stock argenx SE
 21.93B -
GENMAB A/S Stock Genmab A/S
 18.59B
  1. Stock Market
  2. Equities
  3. KROS Stock
  4. Charts Keros Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW